14-100538043-G-C

Position:

• chr14-100538043-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_001385089.1(BEGAIN):​c.1765C>G​(p.Arg589Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

• Frequency: Genomes: not found (cov: 33)
• Consequence: BEGAIN NM_001385089.1 missense
• Clinical Significance: Uncertain significance criteria provided, single submitter U:1
• Conservation: PhyloP100: 1.42

Genes affected

BEGAIN (HGNC:24163): (brain enriched guanylate kinase associated) Predicted to be involved in regulation of postsynaptic neurotransmitter receptor activity. Predicted to act upstream of or within evoked excitatory postsynaptic potential. Predicted to be located in dendrite; nucleus; and presynapse. Predicted to be active in glutamatergic synapse and postsynapse. [provided by Alliance of Genome Resources, Apr 2022]

BEGAIN (HGNC:):

ACMG classification

Verdict is Uncertain_significance. Variant got 2 ACMG points.

• PM2: Very rare variant in population databases, with high coverage

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
BEGAIN	NM_001385089.1	c.1765C>G	p.Arg589Gly	missense_variant	7/7	ENST00000554140.3	NP_001372018.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
BEGAIN	ENST00000554140.3	c.1765C>G	p.Arg589Gly	missense_variant	7/7	5	NM_001385089.1	ENSP00000451125.2

Frequencies

GnomAD3 genomes Cov.: 33

GnomAD4 exome Cov.: 31

GnomAD4 genome Cov.: 33

ClinVar

Significance: Uncertain significance

Submissions summary: Uncertain:1

Revision: criteria provided, single submitter

Submissions by phenotype

not specified Uncertain:1

Uncertain significance, criteria provided, single submitter

clinical testing

Ambry Genetics

Apr 12, 2023

The c.1708C>G (p.R570G) alteration is located in exon 6 (coding exon 6) of the BEGAIN gene. This alteration results from a C to G substitution at nucleotide position 1708, causing the arginine (R) at amino acid position 570 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Benign	0.21
BayesDel_addAF	Pathogenic	0.19	D
BayesDel_noAF	Uncertain	0.040
CADD	Benign	18
DANN	Uncertain	0.98
DEOGEN2	Benign	0.17	.;T;.;T
Eigen	Benign	-0.19
Eigen_PC	Benign	-0.38
FATHMM_MKL	Benign	0.72	D
LIST_S2	Uncertain	0.93	D;.;D;D
M_CAP	Pathogenic	0.42	D
MetaRNN	Uncertain	0.67	D;D;D;D
MetaSVM	Benign	-0.30	T
MutationAssessor	Uncertain	2.3	.;M;.;M
PrimateAI	Pathogenic	0.83	D
PROVEAN	Pathogenic	-5.6	.;D;.;D
REVEL	Benign	0.26
Sift	Uncertain	0.0010	.;D;.;D
Sift4G	Uncertain	0.0090	.;D;.;D
Polyphen		1.0	.;D;.;D
Vest4		0.54, 0.54
MutPred		0.28		.;Gain of catalytic residue at G572 (P = 0);.;Gain of catalytic residue at G572 (P = 0);
MVP		0.43
MPC		1.5
ClinPred		0.99	D
GERP RS		-0.28
Varity_R		0.63
gMVP		0.38

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr14-101004380;